CBLL CeriBell, Inc.
$27.22▲ +0.70%
Healthcare
Other
After hours
$27.22▲ +0.00%
Oct 27, 4:41 PM ET
Volume 1.16M
Avg Volume (10D) 562.5K
Key Metrics & Fundamentals
Market Cap
$1.04B
P/E Ratio
–
Div Yield
0.00%
52W Range
10.85 - 28.11
% vs 50 MA
9.94%
% vs 200 MA
31.39%
RSI-14
59.6
MACD Histogram
+0.1300
Beta (1Y vs SPY)
1.21
Free Cash Flow
-$12.18M
Gross Rev
$28.10M
Gross Profit
$25.94M
EBITDA
-$18.59M
COGS
$2.16M
Operating Exp
$45.92M
Operating Income
-$19.98M
EBIT
-$19.98M
Pretax Income
-$19.27M
Net Income
-$19.27M
EPS (Diluted)
-0.51
Price & Volume History
Loading chart…
Recent News
3 AI Stocks To Own In October 2026
Simply Wall St. · Oct 25, 2026 4:10 PM ET
Pfizer And 2 Other AI Healthcare Stocks To Watch
Simply Wall St. · Oct 24, 2026 6:09 PM ET
Ceribell to Report Third Quarter 2026 Financial Results on November 3, 2026
GlobeNewswire · Oct 20, 2026 4:05 PM ET
CeriBell And These 2 AI Stocks To Watch
Simply Wall St. · Oct 18, 2026 3:12 PM ET
3 AI Healthcare Stocks To Own In October 2026
Simply Wall St. · Oct 17, 2026 5:09 PM ET
Is CeriBell’s (CBLL) Expanded EEG Software Deepening Its Moat in Critical Care Monitoring?
Simply Wall St. · Oct 14, 2026 7:22 PM ET
CeriBell (CBLL) After FDA Clearance Looks Pricey Despite Stronger Adoption Hopes
Simply Wall St. · Oct 13, 2026 6:18 PM ET
CeriBell Receives FDA Clearance for Platform Software Update
MT Newswires · Sep 30, 2026 7:32 AM ET
Ceribell Receives FDA 510(k) Clearance for Quantitative EEG Trending and Amplitude-Integrated EEG Analysis
GlobeNewswire · Sep 30, 2026 7:00 AM ET
CeriBell Expands EEG Platform Beyond Seizures With Delirium, Pediatric Push
MarketBeat · Aug 12, 2026 11:04 AM ET
Financial Overview - Income Statement
Quarterly
Jun 2026
See CBLL's money flow as a full page
Social Sentiment
Loading Reddit posts…
AI Analysis
Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.
Not financial advice.
All data, scores, charts, and analysis on this site are provided for informational and educational
purposes only and do not constitute financial, investment, legal, or tax advice.
Past performance is not indicative of future results.
See our Legal Notice for full details.